Benjamin Sun, MD

Benjamin Sun, MD

Cardiothoracic Surgeon

Dr. Benjamin Sun is a cardiac surgeon and researcher at Minneapolis Heart Institute Foundation® and surgical director of heart failure at Minneapolis Heart Institute®. He specializes in complex aortic and mitral valve surgery, heart transplantation, aortic root and aortic arch surgery, mechanical support, artificial heart and congestive heart failure surgery.

Minneapolis Heart Institute® at Abbott Northwestern Hospital is recognized internationally as one of the world’s leading providers of heart and vascular care, offering an Integrated Cardiovascular Care Model, involving premier medical care with top-ranked physicians throughout the Midwest.

Minneapolis Heart Institute Foundation® (MHIF) is an independent, nonprofit organization that partners with world-renowned physicians to lead world-class cardiovascular research and education to benefit patients around the world. All of this work is guided by the MHIF vision - to create a world without heart and vascular disease.

Back to Stem Cell Team Back to Heart Failure Team Back to Valve Team
 

Benjamin Sun, MD
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.